AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) - Share price - Overview

Stock Report

AcelRx Pharmaceuticals Inc ACRX

Last Price
$3.10

Day Change
0.10|3.33%

As of 20/07/2017
19:34:12 EDT | USD
Minimum 15 Minutes Delay.

Last Close3.00
Day Range2.95 - 3.15
Mkt Cap140.70Mil
52-Wk Range1.95 - 4.08
Yield %-
ISINUS00444T1007
Volume916,457
P/E-2.95
P/S8.06
P/CF-4.58

Share Price

Financials
201420152016
More ...
Income Statement
Revenue5.2219.2617.36
Operating Income-37.65-19.95-31.96
Net Income-33.35-24.40-43.16
Basic EPS-0.77-0.55-0.95
Avg. Diluted Shares Outstanding444445
Balance Sheet
Current Assets76.30118.9589.05
Non Current Assets10.158.8410.94
Total Assets86.45127.7999.99
Current Liabilities13.7312.7810.19
Total Liabilities39.7994.67105.33
Total Equity46.6633.11-5.34
Cash Flow
Operating Cash Flow-34.46-19.95-29.40
Capital Expenditure-5.51-1.46-3.72
Free Cash Flow-39.96-21.41-33.12

In millions, except "Basic EPS". Currency is USD.

Company Profile

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

38
Key Stats
More ...
Price/Earning TTM-2.86
Price/Book-6.93
Price/Sales TTM7.80
Rev Growth (3 year avg)-16.21
EPS Growth (3 year avg)-
Operating Margin % TTM-184.12
Net Margin % TTM-248.64
ROE TTM-310.75
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.